⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VSTM News
Verastem, Inc.
Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
businesswire.com
VSTM
Verastem Oncology Announces Proposed Public Offering of Common Stock
businesswire.com
VSTM
Verastem Oncology to Present at Upcoming Investor Conferences
businesswire.com
VSTM
Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
businesswire.com
VSTM
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
VSTM
VSTM